Posted by: Albany Cornea | Center For Eye Care Excellence in Keratoconus
A keratoconus diagnosis can feel alarming, especially when it comes during the teenage years or early adulthood. But an early diagnosis is actually the best possible scenario.
When the condition is caught before significant corneal distortion develops, patients have access to treatments that can protect their vision for decades. The challenge is that not all treatments do the same thing, and choosing the right one depends on what you’re trying to accomplish: correct vision, stop progression, or both.
What is Early Keratoconus?
Keratoconus is a progressive condition in which the cornea gradually thins and steepens, eventually bulging into a cone-like shape that distorts how light enters the eye. Patients often notice blurring and distortion rather than simple nearsightedness, along with sensitivity to light and halos around light sources at night.
The disease typically begins in the teenage years and tends to progress through a patient’s 20s and into their 30s before stabilizing.
“Early” keratoconus refers to the stage before significant scarring or structural compromise has occurred. At this point, the cornea has begun to change, but the damage is still limited. This distinction matters because early-stage treatment can target the disease itself, not just the symptoms.
Do Glasses and Soft Contact Lenses Help Keratoconus?
In the earliest phase of keratoconus, standard glasses or soft contact lenses may provide adequate vision correction. The corneal shape has not yet changed dramatically, so conventional optics can still compensate for the refractive error. For some patients, this is enough for months or even years.
Over time, though, the irregular surface of a steepening cornea becomes harder to correct with soft lenses, which conform to the shape of the eye rather than neutralizing it. Blurring and ghosting worsen, and patients begin to notice that their prescriptions change more frequently. This progression is the clearest signal that glasses and soft lenses alone are no longer a complete answer.
Corneal Cross-Linking: The Gold Standard for Halting Progression
When keratoconus is active and progressing, the most effective treatment to stop that progression is corneal cross-linking.
Center for Eye Care Excellence was the first practice in Northeastern New York to offer FDA-approved corneal cross-linking, and it remains one of the most impactful interventions the practice provides for keratoconus patients.
The procedure works by applying riboflavin (vitamin B2) eye drops to the cornea and then exposing the tissue to ultraviolet light. This creates new bonds between the collagen fibers that make up the cornea’s structure, stiffening the tissue and significantly reducing or stopping the forward progression of the cone shape. Clinical research has demonstrated that cross-linking can stabilize the cornea within three to twelve months after treatment.
What makes cross-linking particularly valuable in the early stage is that it works best when corneal tissue is still relatively thick and the structural integrity is still intact. Performing cross-linking on a cornea that has already thinned significantly carries more risk and produces less predictable results. Patients who act early tend to preserve more of their natural corneal architecture, which protects their options for the future.
Cross-linking does not reverse the shape changes that have already occurred. Its goal is stabilization, not correction. For that reason, most patients continue using corrective lenses after the procedure.
Specialty Contact Lenses: Managing Vision While Protecting the Cornea
As the corneal surface becomes more irregular, specialty contact lenses provide a level of vision correction that soft lenses and glasses cannot match.
Rigid gas-permeable lenses, scleral lenses, and hybrid lenses all work by creating a smooth, uniform refracting surface over the irregular cornea, effectively masking the distortion caused by the cone shape.
Scleral lenses have become an especially effective option for many keratoconus patients. These large-diameter lenses vault completely over the cornea and rest on the sclera (the white of the eye), which means they do not touch the steepened area at all. This reduces irritation and improves both comfort and visual clarity. Patients who previously found rigid lenses intolerable often do well with sclerals.
Fitting specialty lenses for an irregular cornea requires detailed corneal mapping and a specialist with experience in complex lens design. Cornea diseases that alter corneal shape, including keratoconus, require a higher level of clinical expertise than routine contact lens fitting, so make sure to see a specialist like those at Center for Eye Care Excellence.
How is Keratoconus Treatment Monitored?
Early keratoconus management is not a one-time decision. Because the disease can progress at different rates in different patients, regular monitoring is essential to know when to intervene and whether current treatment is holding.
Corneal thickness testing is a quick, painless measurement that tracks structural changes over time. When combined with corneal topography and tomography, it gives the physician a detailed picture of how the cornea’s shape and thickness are evolving. These measurements are how doctors confirm that cross-linking has successfully stabilized the cornea, and they are also how early changes get caught before they become severe.
Patients with known or suspected keratoconus should expect to have corneal imaging performed at regular intervals, typically every six to twelve months during the active phase of the disease. The frequency can ease once stability is confirmed.
When Early Treatment Prevents More Invasive Surgery Later
One of the strongest arguments for treating keratoconus aggressively in the early stage is what it can help patients avoid down the road. Patients who receive cross-linking before the cornea has significantly thinned are far less likely to reach the point where surgical intervention becomes necessary.
For patients with moderate to advanced keratoconus who did not receive early treatment, options like Intacs corneal inserts or the newer Corneal Tissue Addition Keratoplasty (CTAK) may be needed to reshape and reinforce the cornea. In the most advanced cases, a full corneal transplant may still be required. These procedures carry longer recovery times, more complexity, and greater risk than cross-linking performed at an early stage.
None of this means that patients who require more advanced treatment are without options. Center for Eye Care Excellence offers the full spectrum of keratoconus care, including CTAK. But the simplest, most effective path through keratoconus is one that begins with early detection and timely cross-linking before the disease has room to progress.
Concerned about changes in your vision and whether keratoconus could be the cause? Schedule an appointment at Center For Eye Care Excellence in Slingerlands, NY.
